<DOC>
	<DOCNO>NCT02010281</DOCNO>
	<brief_summary>This study aim evaluate long term efficacy 25 week repeat session magnetic transcranial stimulation motor cortex prefrontal cortex average pain intensity , quality life , sleep , neuropathic symptom , return work , patient peripheral neuropathic pain . The medical device study : transcranial magnetic stimulator ( TMS ) .</brief_summary>
	<brief_title>Analgesic Effects rTMS Peripheral Neuropathic Pain</brief_title>
	<detailed_description>The present multicenter parallel session randomize placebo control study ( 4 French center ) aim evaluate long term efficacy 25 week repeat session magnetic transcranial stimulation motor cortex prefrontal cortex average pain intensity ( primary outcome ) several secondary outcome measure ( e.g . quality life , sleep , neuropathic symptom , return work ) , patient peripheral neuropathic pain . The patient randomize receive one 3 treatment arm : rTMS motor cortex , rTMS prefrontal cortex , placebo ( sham stimulation ) motor prefrontal cortex . The study double blind , eg patient investigator know nature treatment . stimulation protocol consist induction phasse 5 daily session maintenance phase several session : 3 session week apart , 3 session fortnight apart , 3 session 3 week apart .</detailed_description>
	<mesh_term>Neuralgia</mesh_term>
	<criteria>1 . Peripheral neuropathic pain ( unilateral bilateral ) probable define accord criterion propose 2008 ( Treede et al 2008 ) , 2 . Diagnostic DN4 questionnaire score great equal 4/10 ( Bouhassira et al 2005 ) , 3. chronic pain , average intensity great equal 40/100 4 . Daily almost daily pain ( least 4 day 7 ) 5 . This pain present 6 month 6 . Patients 18 75 year old 7 . Patients sign informed consent , 8 . Patients whose pain medication stable 15 day inclusion , need change study period , 9 . Patients monitor study period ( 30 week ) 10 . Patients insured health insurance plan entitle . 1 . Previous treatment use rTMS , 2 . Work Accident dispute 3. rTMS Consindications ( ECT treatment previous month , epilepsy / history epilepsy ; history head trauma , neurosurgical lesion , intracranial hypertension , metal clip , pacemaker , pregnant lactate woman ) 4 . Abuse drug psychoactive substance ( DSM IV ) 5 . Central neuropathic pain , 6 . Neuropathic pain within framework progressive disease ( HIV , cancer , nonstabilized system disease ) 7 . Neuropathic pain limit extent , neuroma type 8 . Current major depression psychosis accord DSM IV criterion , 9 . Intermittent pain , 10 . Pain less six month , 11 . Presence another pain severe one justifying inclusion 12 . Lack proper filling selfassessment pain baseline randomization ( least 4 weekly pain score 7 day ) notebooks 13 . Lack stability pain score two successive evaluation , define change 30 % two assessment average pain short questionnaire pain first two visit inclusion 14 . Subject unable understand inform consent , guardianship , 15 . Subject refuse stop stop prohibit treatment study , 16 . Patients participate another research protocol involve drug within 30 day enrollment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>rTMS</keyword>
	<keyword>peripheral neuropathic pain</keyword>
	<keyword>randomize control trial</keyword>
</DOC>